AVEO Pharmaceuticals (AVEO) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q2 EPS of ($0.35), $0.09 better than the analyst estimate of ($0.44).
For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
